Search

Home > JAMA Network > JAMA Oncology : Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer
Podcast: JAMA Network
Episode:

JAMA Oncology : Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-Risk Breast Cancer
Category: Science & Medicine
Duration: 00:34:49
Publish Date: 2021-09-16 15:00:00
Description:

Interview with Laura J. Esserman, MD, and W. Fraser Symmans, MD, authors of Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
Total Play: 0